(89)Zr-DFO-Isatuximab for CD38-Targeted ImmunoPET Imaging of Multiple Myeloma and Lymphomas

[Image: see text] Multiple myeloma (MM) is the second most prevalent hematological malignancy. It remains incurable despite the availability of novel therapeutic approaches, marking an urgent need for new agents for noninvasive targeted imaging of MM lesions. CD38 has proven to be an excellent bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrero Alvarez, Natalia, Michel, Alexa L., Viray, Tara D., Mayerhoefer, Marius E., Lewis, Jason S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308590/
https://www.ncbi.nlm.nih.gov/pubmed/37396228
http://dx.doi.org/10.1021/acsomega.3c00624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308590/
https://www.ncbi.nlm.nih.gov/pubmed/37396228
http://dx.doi.org/10.1021/acsomega.3c00624

Ejemplares similares